342 related articles for article (PubMed ID: 32362840)
1. Metabolic Checkpoints in Rheumatoid Arthritis.
Pucino V; Certo M; Varricchi G; Marone G; Ursini F; Rossi FW; De Paulis A; Mauro C; Raza K; Buckley CD
Front Physiol; 2020; 11():347. PubMed ID: 32362840
[TBL] [Abstract][Full Text] [Related]
2. Metabolites as drivers and targets in rheumatoid arthritis.
Hanlon MM; Canavan M; Barker BE; Fearon U
Clin Exp Immunol; 2022 Jun; 208(2):167-180. PubMed ID: 35020864
[TBL] [Abstract][Full Text] [Related]
3. Altered metabolic pathways regulate synovial inflammation in rheumatoid arthritis.
Fearon U; Hanlon MM; Wade SM; Fletcher JM
Clin Exp Immunol; 2019 Aug; 197(2):170-180. PubMed ID: 30357805
[TBL] [Abstract][Full Text] [Related]
4. Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications.
Fearon U; Hanlon MM; Floudas A; Veale DJ
Nat Rev Rheumatol; 2022 Jul; 18(7):398-414. PubMed ID: 35440762
[TBL] [Abstract][Full Text] [Related]
5. The Involvement of Glucose and Lipid Metabolism Alteration in Rheumatoid Arthritis and Its Clinical Implication.
Luo TT; Wu YJ; Yin Q; Chen WG; Zuo J
J Inflamm Res; 2023; 16():1837-1852. PubMed ID: 37131409
[TBL] [Abstract][Full Text] [Related]
6. Immunometabolism Dysfunction in the Pathophysiology and Treatment of Rheumatoid Arthritis.
Masoumi M; Hashemi N; Moadab F; Didehdar M; Farahani R; Khorramdelazad H; Sahebkar A; Johnston TP; Karami J
Curr Med Chem; 2023; 30(27):3119-3136. PubMed ID: 36082869
[TBL] [Abstract][Full Text] [Related]
7. Macrophages: The Good, the Bad, and the Gluttony.
Ross EA; Devitt A; Johnson JR
Front Immunol; 2021; 12():708186. PubMed ID: 34456917
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis.
Qiu J; Wu B; Goodman SB; Berry GJ; Goronzy JJ; Weyand CM
Front Immunol; 2021; 12():652771. PubMed ID: 33868292
[TBL] [Abstract][Full Text] [Related]
9. The interplay between inflammation and metabolism in rheumatoid arthritis.
Chimenti MS; Triggianese P; Conigliaro P; Candi E; Melino G; Perricone R
Cell Death Dis; 2015 Sep; 6(9):e1887. PubMed ID: 26379192
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis.
Cai WW; Yu Y; Zong SY; Wei F
Inflamm Res; 2020 Nov; 69(11):1087-1101. PubMed ID: 32797249
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of rheumatoid arthritis.
Weyand CM; Goronzy JJ
Med Clin North Am; 1997 Jan; 81(1):29-55. PubMed ID: 9012754
[TBL] [Abstract][Full Text] [Related]
12. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
Bläss S; Engel JM; Burmester GR
Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
van Hamburg JP; Tas SW
J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
[TBL] [Abstract][Full Text] [Related]
14. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
15. Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis.
de Jong TA; Semmelink JF; Denis SW; van de Sande MGH; Houtkooper RHL; van Baarsen LGM
J Autoimmun; 2023 Jan; 134():102974. PubMed ID: 36512907
[TBL] [Abstract][Full Text] [Related]
16. Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?
Sanchez-Lopez E; Cheng A; Guma M
J Clin Med; 2019 May; 8(5):. PubMed ID: 31137815
[TBL] [Abstract][Full Text] [Related]
17. Differential Metabolome in Rheumatoid Arthritis: a Brief Perspective.
Agnihotri P; Monu ; Ramani S; Chakraborty D; Saquib M; Biswas S
Curr Rheumatol Rep; 2021 Apr; 23(6):42. PubMed ID: 33913028
[TBL] [Abstract][Full Text] [Related]
18. Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis.
Okada T; Tsukano H; Endo M; Tabata M; Miyata K; Kadomatsu T; Miyashita K; Semba K; Nakamura E; Tsukano M; Mizuta H; Oike Y
Am J Pathol; 2010 May; 176(5):2309-19. PubMed ID: 20304962
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity drives pathogenesis of rheumatoid arthritis.
Edilova MI; Akram A; Abdul-Sater AA
Biomed J; 2021 Apr; 44(2):172-182. PubMed ID: 32798211
[TBL] [Abstract][Full Text] [Related]
20. Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis.
Mondal S; Saha S; Sur D
Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):330-340. PubMed ID: 38478467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
